An immune-based assay for HIV disease management

R Kowalski1, J Woodcock, P Sottong

  • 1Cylex Inc., 8980-I Old Annapolis Rd., Columbia, MD 21045, USA. rkowalski@cylex.net

American Clinical Laboratory
|August 17, 2001
PubMed
Summary

Accurate HIV patient monitoring requires assessing cell-mediated immunity (CMI) beyond CD4+ T cell counts and viral load. An in vitro CMI test offers a rapid method to better reflect a patient's clinical status and guide treatment.